BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26837418)

  • 1. Grhl3 induces human epithelial tumor cell migration and invasion via downregulation of E-cadherin.
    Zhao P; Guo S; Tu Z; Di L; Zha X; Zhou H; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):266-74. PubMed ID: 26837418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion.
    Wang X; Zheng M; Liu G; Xia W; McKeown-Longo PJ; Hung MC; Zhao J
    Cancer Res; 2007 Aug; 67(15):7184-93. PubMed ID: 17671186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
    Nam EH; Lee Y; Park YK; Lee JW; Kim S
    Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
    Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
    J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription.
    Yan HB; Wang XF; Zhang Q; Tang ZQ; Jiang YH; Fan HZ; Sun YH; Yang PY; Liu F
    Carcinogenesis; 2014 Apr; 35(4):867-76. PubMed ID: 24293408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
    Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
    J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
    Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.
    Wang XX; Zhu Z; Su D; Lei T; Wu X; Fan Y; Li X; Zhao J; Fu L; Dong JT; Fu L
    Hum Pathol; 2011 Oct; 42(10):1410-9. PubMed ID: 21419475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition.
    Lin YC; Lee YC; Li LH; Cheng CJ; Yang RB
    J Cell Sci; 2014 Jan; 127(Pt 1):85-100. PubMed ID: 24213532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
    Li X; Kong X; Huo Q; Guo H; Yan S; Yuan C; Moran MS; Shao C; Yang Q
    Cancer Sci; 2011 Jun; 102(6):1151-7. PubMed ID: 21371176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
    Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.